Anteilseigner
Anthony P. Mack (25,47 %) Tower Research Capital LLC (0,12 %) Eric Floyd,
PhD, EMBA (0,07 %) Jeffrey A. Gudin,
MD (0,06 %) Signature Resources Capital Management LLC (0,04 %) Thani Jambulingam,
PhD (0,01 %) FSC Securities Corp. (0,01 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,00 %) Wells Fargo Bank, NA (Private Banking) (0,00 %)
Kontakt
Virpax Pharmaceuticals Inc.